This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Summer;44(3):1-10.

doi: 10.1097/00004397-200404430-00003.

Adjunctive therapies for proliferative vitreoretinopathy

Jennifer K Sun¹, Jorge G Arroyo

Affiliations

PMID: 15211172
DOI: 10.1097/00004397-200404430-00003

Review

Adjunctive therapies for proliferative vitreoretinopathy

Jennifer K Sun et al. Int Ophthalmol Clin. 2004 Summer.

. 2004 Summer;44(3):1-10.

doi: 10.1097/00004397-200404430-00003.

Authors

Jennifer K Sun¹, Jorge G Arroyo

Affiliation

¹ Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.

PMID: 15211172
DOI: 10.1097/00004397-200404430-00003

No abstract available

PubMed Disclaimer

Similar articles

[Pharmacological adjuvants for surgical treatment of proliferative vitreoretinopathy].
Scheer S, Morel C, Touzeau O, Sahel JA, Laroche L. Scheer S, et al. J Fr Ophtalmol. 2004 Nov;27(9 Pt 1):1051-9. doi: 10.1016/s0181-5512(04)96264-x. J Fr Ophtalmol. 2004. PMID: 15557870 Review. French.
Proliferative Vitreoretinopathy: A Review.
Idrees S, Sridhar J, Kuriyan AE. Idrees S, et al. Int Ophthalmol Clin. 2019 Winter;59(1):221-240. doi: 10.1097/IIO.0000000000000258. Int Ophthalmol Clin. 2019. PMID: 30585928 Free PMC article. Review.
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.
Charteris DG. Charteris DG. Br J Ophthalmol. 1995 Oct;79(10):953-60. doi: 10.1136/bjo.79.10.953. Br J Ophthalmol. 1995. PMID: 7488586 Free PMC article. Review. No abstract available.
Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.
Jonas JB, Hayler JK, Panda-Jonas S. Jonas JB, et al. Br J Ophthalmol. 2000 Sep;84(9):1064-7. doi: 10.1136/bjo.84.9.1064. Br J Ophthalmol. 2000. PMID: 10966969 Free PMC article.
Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR).
Pastor JC, Rodríguez E, Marcos MA, Lopez MI. Pastor JC, et al. Ophthalmic Res. 2000 Jan-Feb;32(1):25-9. doi: 10.1159/000055583. Ophthalmic Res. 2000. PMID: 10657752

See all similar articles

Cited by

Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.
Chen X, Yang W, Deng X, Ye S, Xiao W. Chen X, et al. Mol Vis. 2020 Jul 29;26:517-529. eCollection 2020. Mol Vis. 2020. PMID: 32818015 Free PMC article.
Vitreous Substitutes.
Foster WJ. Foster WJ. Expert Rev Ophthalmol. 2008 Apr;3(2):211-218. doi: 10.1586/17469899.3.2.211. Expert Rev Ophthalmol. 2008. PMID: 19343097 Free PMC article.
Effect of Adjuvant Mitomycin-C on Recurrent Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy Managed by Relaxing Retinotomy and Retinectomy.
Gürelik İG, Özdemir HB, Köse BG, Acar AB. Gürelik İG, et al. J Ophthalmol. 2025 Mar 19;2025:9927416. doi: 10.1155/joph/9927416. eCollection 2025. J Ophthalmol. 2025. PMID: 40144767 Free PMC article.
Timing and outcomes after silicone oil removal in proliferative vitreoretinopathy: a retrospective clinical series.
Tavares RLP, Nóbrega MJ, Nóbrega FAJ, De Novelli FJ, De Oliveira CAC. Tavares RLP, et al. Int J Retina Vitreous. 2015 Apr 15;1:2. doi: 10.1186/s40942-015-0002-y. eCollection 2015. Int J Retina Vitreous. 2015. PMID: 27847595 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information